Found: 16
Select item for more details and to access through your institution.
Exploring content and psychometric validity of newly developed assessment tools for itch and skin pain in atopic dermatitis.
- Published in:
- Journal of Patient-Reported Outcomes, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1186/s41687-019-0128-z
- By:
- Publication type:
- Article
Baricitinib Rapidly Improves Skin Pain Resulting in Improved Quality of Life for Patients with Atopic Dermatitis: Analyses from BREEZE-AD1, 2, and 7.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1599, doi. 10.1007/s13555-021-00577-x
- By:
- Publication type:
- Article
Correction to: Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™): a clinical outcome measure for the severity of atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 4, p. 531, doi. 10.1111/bjd.21615
- By:
- Publication type:
- Article
Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate‐to‐severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo‐controlled, phase III clinical trial (BREEZE‐AD4)*
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 3, p. 338, doi. 10.1111/bjd.21630
- By:
- Publication type:
- Article
Psychometric properties of morning joint stiffness duration and severity measures in patients with moderately to severely active rheumatoid arthritis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Psychometric properties of the single-item measure, severity of worst tiredness, in patients with moderately to severely active rheumatoid arthritis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Patient Perceptions of Unmet Medical Need in Rheumatoid Arthritis: A Cross-Sectional Survey in the USA.
- Published in:
- Rheumatology & Therapy, 2019, v. 6, n. 3, p. 461, doi. 10.1007/s40744-019-00168-5
- By:
- Publication type:
- Article
Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial.
- Published in:
- Rheumatology & Therapy, 2019, v. 6, n. 3, p. 409, doi. 10.1007/s40744-019-0164-4
- By:
- Publication type:
- Article
Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulinresistant patients with type 2 diabetes: analysis of a randomized clinical trial.
- Published in:
- Health & Quality of Life Outcomes, 2016, v. 14, p. 1, doi. 10.1186/s12955-016-0541-4
- By:
- Publication type:
- Article
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical Trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Conversion of Functional Assessment of Chronic Illness Therapy–Fatigue to Patient‐Reported Outcomes Measurement Information System Fatigue Scores in Two Phase III Baricitinib Rheumatoid Arthritis Trials.
- Published in:
- Arthritis Care & Research, 2021, v. 73, n. 4, p. 481, doi. 10.1002/acr.24144
- By:
- Publication type:
- Article
Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment.
- Published in:
- Arthritis Research & Therapy, 2017, v. 19, p. 1, doi. 10.1186/s13075-017-1410-1
- By:
- Publication type:
- Article